[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100465039":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":10,"responsibleParty":18,"collaborators":10,"id":22,"slug":10,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":25,"acronym":10,"eligibilityCriteria":26,"healthyVolunteers":23,"sex":27,"minAge":10,"maxAge":10,"enrollmentInfo":28,"targetDuration":10,"studyType":31,"phases":10,"briefSummary":32,"conditions":33,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":10},{"fullName":5,"class":6},"Tata Memorial Centre","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients underwent TURBT",null,"Patients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH and found to have NMIBC (either low risk or high risk)",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Mahendra Pal, DNB","CONTACT","9757091924","mahen1197@gmail.com",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Dr. Mahendra Pal","Professor Urology Oncology","100465039",false,"NCT05335512","Intravesical BCG: is the Urinary Bladder Ready to Receive it","Inclusion Criteria:\n\nPatients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH and found to have NMIBC (either low risk or high risk) Patient gives consent will be included (after explaining about the study).\n\nExclusion Criteria:\n\n1. Patient who has visible tumor on first or any subsequent cystoscopy.\n2. On histopathology found to have muscle invasive bladder cancer.\n3. Patient having urinary tract infection before cystoscopy","ALL",{"count":29,"type":30},100,"ESTIMATED","OBSERVATIONAL","Prospective cohort and Prospective observational study which aims To define the healing time-frame of the resected area of the bladder after TURBT. and also to validate a grading system of healing of the bladder mucosa after TURBT. To assess the factors influencing bladder healing is also one of the secondary objectives.",[34],"Non-Invasive Bladder Urothelial Carcinoma","NOT_YET_RECRUITING","2022-06-07",{"date":38,"type":39},"2022-06-09","ACTUAL",{"date":41,"type":30},"2022-09-01",{"date":43,"type":30},"2028-09-01",{"name":5,"class":6}]